Orexin-1 receptor antagonist SB-334867 reduces the acquisition and expression of cocaine-conditioned reinforcement and the expression of amphetamine-conditioned reward
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Preclinical evidence suggests an important role of the brain orexin system in behaviours related to drug addiction. This study aimed at assessing the effect of the orexin-1 receptor antagonist SB-334867 on aspects of psychostimulant-conditioned behaviours that are thought to contribute to the maintenance of and relapse to psychostimulant drug use. Rats were first allowed to nose poke for cocaine infusions associated with a cue light presentation (conditioned stimulus; CS) over five daily sessions. Subsequently, drug-free rats were tested for the acquisition of a new response in which presses on a novel active lever led to the presentation of the previously paired CS. We tested SB-334867 in two conditions, SB-334867 was given either before each cocaine self-administration or before the initial four sessions of acquisition for a novel instrumental responding paired with the CS (conditioned reinforcement). The effect of SB-334867 was also tested on the expression of conditioned place preference to d-amphetamine. The rats treated with SB-334867 before each cocaine self-administration session subsequently showed reduced active lever pressing compared with controls in the initial days of the conditioned reinforcement. In the second study, untreated rats showed normal acquisition of discriminated responding preferential for the lever providing the cocaine cue. In contrast, SB-334867 decreased the number of active lever pressing (compared with the control) with significant effects in all sessions. Finally, SB-334867 blocked the expression of d-amphetamine-induced conditioned place preference. These results suggest that orexin-1 receptor antagonism could offer therapeutic potential in reducing the impact of psychostimulant-predictive stimuli that contribute to compulsive drug seeking in human drug users.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurons containing hypocretin (orexin) project to multiple neuronal systems
Peyron, C., Tighe, D. K., van den Pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe, J. G., & Kilduff, T. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09996.1998 · Cited by 3,466 · cited 6×
“Orexin-containing fibres project throughout the brain with the strongest innervations towards midbrain structures, including monoaminergic nuclei such as the dorsal raphe and locus coeruleus and to a lesser extent the ventral tegmental area (VTA), prefrontal cortex, hippocampus, basolateral amygdala, bed nucleus of th…”
BackgroundInfluentialThe incentive sensitization theory of addiction: some current issues
Robinson, T. E., & Berridge, K. C. (2008) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.0093 · Cited by 1,717 · cited 1×
“…response to the cocaine CS is thought to be driven by the intrinsic incentive value of the CS, which is dissociable from the CS reward predictive property and cannot be attributed to the expression of a habit-like instrumental response (Everitt et al., 2001; Robinson and Berridge, 2008).”
BackgroundIncentive-sensitization and addiction
Robinson, T. E., & Berridge, K. C. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.9611038.x · Cited by 1,435 · cited 2×
“In conclusion, these preclinical results support the idea that the orexin system is implicated in different phases of psychostimulant addiction and that the orexin-1 receptor may be an important target in preventing relapse to drugseeking behaviour (Robinson and Berridge, 2001; Lawrence et al., 2006; Nair et al., 2008…”
BackgroundA role for lateral hypothalamic orexin neurons in reward seeking
Harris, G. C., Wimmer, M., & Aston-Jones, G. (2005) · Nature · doi:10.1038/nature04071 · Cited by 1,311 · cited 2×
“For instance, orexin-A injected into the VTA, reinstated morphine reward seeking in a conditioned place preference (CPP) experiment, suggesting that orexins may regulate the reward processing through the activation of the mesocorticolimbic dopamine system (Harris et al., 2005).”
BackgroundA Role for Brain Stress Systems in Addiction
Koob, G. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.012 · Cited by 1,056 · cited 1×
“Conversely, SB-334867 reduced the cue-induced or stress-induced reinstatement of alcohol, cocaine or sucrose-seeking behaviour (Lawrence et al., 2006; Koob, 2008; Nair et al., 2008; Richards et al., 2008; Smith et al., 2009).”
BackgroundThe neuropsychological basis of addictive behaviour
Everitt, B. J., Dickinson, A., & Robbins, T. W. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00088-1 · Cited by 808
Borgland, S. L., Taha, S. A., Sarti, F., Fields, H. L., & Bonci, A. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.016 · Cited by 718 · cited 4×
“Moreover, orexin-1 was shown to be involved in the development and expression of a sensitized motor response induced by a chronic dosing regimen with amphetamine or cocaine (Borgland et al., 2006; Quarta et al., 2010).”
BackgroundInfluentialAssociative processes in addiction and reward. The role of amygdala-ventral striatal subsystems
EVERITT, B. J., PARKINSON, J. A., OLMSTEAD, M. C., ARROYO, M., ROBLEDO, P., & ROBBINS, T. W. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09280.x · Cited by 708 · cited 1×
“For example, excitotoxic lesions of the basolateral amygdala prevented the ability of the cocaine-paired CS to support the acquisition of a new instrumental response in rats (Everitt et al., 1999).”
BackgroundHeroin and cocaine intravenous self-administration in rats: Mediation by separate neural systems
Ettenberg, A., Pettit, H. O., Bloom, F. E., & Koob, G. F. (1982) · Psychopharmacology · doi:10.1007/bf00428151 · Cited by 563 · cited 1×
“In support of this hypothesis, earlier studies have shown that the pretreatment with the dopamine antagonist a-flupenthixol, which is thought to block cocaine reinforcement, increased cocaine self-administration (Ettenberg et al., 1982).”
ResultRole for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior
Boutrel, B., Kenny, P. J., Specio, S. E., Martin-Fardon, R., Markou, A., Koob, G. F., & de Lecea, L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507480102 · Cited by 520 · cited 4×
“In the same series of experiments, SB334867 also blocked stress-induced reinstatement of cocaine seeking (Boutrel et al., 2005).”
BackgroundResultInfluential
Cited by
The role of orexin in motivated behaviours
Sakurai, T. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3837 · Cited by 464
The neurobiological basis of narcolepsy
Mahoney, C. E., Cogswell, A., Koralnik, I. J., & Scammell, T. E. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0097-x · Cited by 289
Multiple roles for orexin/hypocretin in addiction
Mahler, S. V., Smith, R. J., Moorman, D. E., Sartor, G. C., & Aston-Jones, G. (2012) · Progress in Brain Research · doi:10.1016/b978-0-444-59489-1.00007-0 · Cited by 215
Sartor, G. C., & Aston-Jones, G. S. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4561-11.2012 · Cited by 109
“Additional studies revealed that the orexin system is involved in several addiction-related behaviors (Boutrel et al., 2005; Harris et al., 2005; Smith et al., 2009, 2010; Sharf et al., 2010; Hutcheson et al., 2011).”
BackgroundOverview of orexin/hypocretin system
Mieda, M., & Sakurai, T. (2012) · Progress in brain research · doi:10.1016/b978-0-444-59489-1.00002-1 · Cited by 64
“…and the expression of amphetamine-conditioned MM&TS 15 reward, suggesting that OX1R antagonists have potential as a treatment for individuals struggling with drug relapse and dependency (Hutcheson et al., 2011), although whether the effects of orexin are the same in humans needs to be confirmed.”
Background
Metadata
- Authors
- Hutcheson, D. M., Quarta, D., Halbout, B., Rigal, A., Valerio, E., & Heidbreder, C.
- Venue
- Behavioural Pharmacology
- Published
- 2011-04
- Volume
- 22
- Issue
- 2
- Pages
- 173-181
- ISSN
- 0955-8810 (ISSN-L)
- OpenAlex
- W2086378665
- Cited by
- 71
- References
- 12
- FWCI
- 2.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.